医薬品開発受託機関・CRO向け臨床試験情報

Citeline

Clinical Trials & the COVID-19 Vaccine

Informa Pharma Intelligence’s Pulse Report

The New Normal for Clinical Trials and Planning for the Future Webinar

Join our panel of experts as they discuss the impact of COVID-19 on clinical trials, the new normal and future pathways to get ahead. Get the latest insights and status on recent clinical trials, the emergence of virtual trials, and what you need to know for success.

Citeline

The Future of Clinical Trials From the Investigator Perspective Webinar

Listen to our podcast “The Future of Clinical Trials From the Investigator Perspective” from earlier this year and register for our upcoming webinar to learn new developments

Citeline Engage: Recruit

A recent survey found 44% of investigators anticipate COVID-19 having a negative impact on their future ability to enroll patients in clinical trials. The adoption of virtual/decentralized trials on a larger, global scale will make the recruitment of patients more complex. To avoid the risk of failure, Citeline Engage can help you recruit experienced investigators with known patient pools and specialized physicians in proximity to support patient referrals.

Citeline Engage: Clinical trial timeline

See how Citeline Engage can help you at every stage of your clinical trial

Exploring Basket and Umbrella Oncology Trials

To increase flexibility and efficiency in drug development, master protocols have emerged as an innovative clinical trial design, including basket and umbrella trials. Learn more about how these approaches are being used within oncology research through an overview of the clinical landscape, trial outcomes and trends.

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Clinical Trial Design Report

Rising costs, patient recruitment issues, shifting regulations, and more are making bringing new drugs to market more difficult than ever. Explore changes in clinical trial design being adopted in response to these challenges with reporting from Pink Sheet.

Taking the High Out of Pain: Exploring Abuse-Deterrent Opioids and Opioid Alternatives

With opioid abuse and deaths in the US at an all-time high, the journey to battle the opioid epidemic continues – keeping drug companies and the FDA working hard to come up with effective alternatives for pain.

Sitetrove: 治験責任医師と治験施設情報のデータベース, Trialtrove: 医療用医薬品の臨床試験情報デー...

Citeline: Global Clinical Trial Intelligence Solutions

Citeline is the industry’s most comprehensive, reliable and up-to-date global clinical trial intelligence suite, designed to help you save time and money by enrolling patients faster. Our team of more than 250 industry experts transform data into knowledge, integrating robust drug, trial, investigator, and site intelligence.

Whitepaper: Taking the 'High' Out of Pain

Twenty years ago, there was a shift in pain management, and it became more common to prescribe opioids for chronic pain.

Pharmaprojects: 医薬品開発パイプラインのデータベース

Pharma RD Annual Review 2019 Supplement New Active Substances Launched During 2018

Take the analysis from the Informa Pharma Intelligence R&D Annual Review 2019 further with the Pharma R&D Annual Review 2019 Supplement: New Active Substances Launched During 2018. This essential whitepaper uses critical data from Pharmaprojects to examine the new entities that were successfully launched to market last year.

Citeline

Horizons in HIV Drug Development – What’s Past is Prologue

While AIDS therapy was once confined to palliative care, clinical progress in the wake of the landmark 1987 approval of zidovudine has seen HIV demoted to a chronic but manageable infection. Following the initial fledgling steps and missteps, the mid-1990s saw the introduction of the now-familiar three-drug combination regimens that raised expectations for a pharmaceutical solution to the epidemic.

Citeline

Depression New Insights Shifting the Treatment Paradigm Whitepaper

Depression affects approximately 1 in 6 Americans, with 10 – 30% of depression patients becoming treatment-resistant. Find out what the pipeline looks like for depression and what the emerging strategies in this area are. This data-packed whitepaper from Informa Pharma Intelligence can now be downloaded – free.

Trialtrove: 医療用医薬品の臨床試験情報データベース

Rheumatoid Arthritis - Old and New Approaches Shifting the Treatment Paradigm

Explore the current and future outlook for rheumatoid arthritis (RA) treatments. Such treatments remain ineffective for the 33% of RA sufferers who are or become unresponsive to treatment, resulting in a high interest in RA drug development to address this unmet need in the marketplace.

Citeline

2017 Completed Clinical Trials: Disease and Sponsor Assessment in 9 Key Tables

Citeline’s completed clinical trial landscape provides a more granular view of how companies are progressing their pipelines and the disease strategies they are pursuing, compared to static pipeline snapshots.